{"id":31993,"date":"2022-12-20T12:24:50","date_gmt":"2022-12-20T11:24:50","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/?p=31993"},"modified":"2022-12-20T14:29:02","modified_gmt":"2022-12-20T13:29:02","slug":"vorhofflimmern-ablationsbehandlungen-im-vormarsch-cme","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2022\/vorhofflimmern-ablationsbehandlungen-im-vormarsch-cme","title":{"rendered":"Vorhofflimmern: Ablationsbehandlungen im Vormarsch \u00a0 [CME]"},"content":{"rendered":"<p>In Deutschland f\u00fchrten im Jahr 2020 &gt;\u00a0400\u00a0Kliniken Katheterablationen am Herzen durch, mit Fallzahlen zwischen 2 und 7.100 pro Einrichtung . In \u00d6sterreich waren es 2019 24\u00a0Zentren, die elektrophysiologische Behandlungen durchf\u00fchrten . Angebot und Bedarf steigen seit Jahren an, wobei in erster Linie die Zahl der Pulmonalvenen-Isolationen (PVI) bei Vorhofflimmern (Vofli) zunimmt . Eine solche Ablation [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In Deutschland f\u00fchrten im Jahr 2020 &gt;\u00a0400\u00a0Kliniken Katheterablationen am Herzen durch, mit Fallzahlen zwischen 2 und 7.100 pro Einrichtung . In \u00d6sterreich waren es 2019 24\u00a0Zentren, die elektrophysiologische Behandlungen durchf\u00fchrten . Angebot und Bedarf steigen seit Jahren an, wobei in erster Linie die Zahl der Pulmonalvenen-Isolationen (PVI) bei Vorhofflimmern (Vofli) zunimmt . Eine solche Ablation [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[4781,185,127,126,129,128,131,3383,5783,1421,187,429,1423,183,574,2743,181],"class_list":["post-31993","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-ablation","tag-absolute-arrhythmie","tag-amiodaron","tag-antiarrhythmika","tag-beta-blocker","tag-betablocker","tag-betarezeptoren-blocker","tag-dronedaron","tag-early-af-studie","tag-flecainid","tag-herzrhythmusstoerungen","tag-kryoablation","tag-propafenon","tag-rhythmusstoerungen","tag-sotalol","tag-vorhofablation","tag-vorhofflimmern"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/31993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=31993"}],"version-history":[{"count":1,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/31993\/revisions"}],"predecessor-version":[{"id":31994,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/31993\/revisions\/31994"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=31993"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=31993"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=31993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}